Re: A lesson on futility analyses from the CETP inhibitors
in response to
by
posted on
May 10, 2017 03:30PM
I meant to add to my post that even with your digging BDAZ into the 3 point MACE information from the combined trials I do not beleieve there were sufficient cases to give us any reasonable information about apabetalone and 3 point MACE.
Please correct me if I am wrong.
Toinv